- Home
- LXEO vs GOOD Comparison
LXEO vs GOOD Comparison
Compare LXEO & GOOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LXEO | GOOD |
|---|---|---|
| Founded | 2017 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Real Estate Investment Trusts |
| Sector | | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 663.5M | 533.4M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | LXEO | GOOD |
|---|---|---|
| Price | $9.93 | $10.67 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 1 |
| Target Price | ★ $18.90 | $11.00 |
| AVG Volume (30 Days) | ★ 1.5M | 571.9K |
| Earning Date | 11-05-2025 | 02-17-2026 |
| Dividend Yield | N/A | ★ 11.25% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.18 |
| Revenue | N/A | ★ $155,250,000.00 |
| Revenue This Year | N/A | $8.62 |
| Revenue Next Year | N/A | $6.28 |
| P/E Ratio | ★ N/A | $58.21 |
| Revenue Growth | N/A | ★ 4.95 |
| 52 Week Low | $1.45 | $10.33 |
| 52 Week High | $10.99 | $16.63 |
Technical Indicators
Market Signals| Indicator | LXEO | GOOD |
|---|---|---|
| Relative Strength Index (RSI) | 52.72 | 44.71 |
| Support Level | $10.02 | $10.33 |
| Resistance Level | $10.99 | $10.72 |
| Average True Range (ATR) | 0.59 | 0.16 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 45.64 | 41.51 |
Price Performance
Historical ComparisonAbout LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.
About GOOD Gladstone Commercial Corporation Real Estate Investment Trust
Gladstone Commercial Corp is a real estate investment trust, which engages in investing and owning net leased industrial, commercial, and retail real property and making long-term industrial and commercial mortgage loans. Its portfolio consists of single-tenant commercial, industrial real properties, and medical properties nationwide. Its principal investment objectives are to generate income from rental properties.